Flavocure Biotech, LLC recently accomplished a major milestone — receiving Orphan Drug designation from the US Food and Drug Administration for their drug to treat acute myeloid leukemia.
Flavocure’s Founder and Executive Chairman, Dr. Henry Lowe, is a notable Jamaican scientist. Flavocure’s achievement is great news for Maryland and for Jamaica.
News of the US FDA approval was announced by the Prime Minister of Jamaica in a ceremony there last week. Several national news outlets covered the story, including The Gleaner and Jamaica Information Services.